Advertisement

Topics

ICON Announces Agreement with Intel Allowing Integration of the Intel Pharma Analytics Platform for Clinical Trials

07:31 EDT 17 Apr 2018 | FinanzNachrichten

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed on prel...

Original Article: ICON Announces Agreement with Intel Allowing Integration of the Intel Pharma Analytics Platform for Clinical Trials

NEXT ARTICLE

More From BioPortfolio on "ICON Announces Agreement with Intel Allowing Integration of the Intel Pharma Analytics Platform for Clinical Trials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...